Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 02/24 06:07:59 pm
80.729 EUR   +0.75%
02/23 INTERCEPT PHARM : ICPT) Files An 8-K Results of Operations and Finan..
02/20 SANOFI : Disclosure of trading in own shares
02/17 SANOFI : JHL Biotech Form Strategic Partnership
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/15/2012 | 02:11pm CET

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
02/23 INTERCEPT PHARMACEUTICALS, INC. (NAS : ICPT) Files An 8-K Results of Operations ..
02/20 SANOFI : Disclosure of trading in own shares
02/17 SANOFI : JHL Biotech Form Strategic Partnership
02/16 REGENERON PHARMACEUTICALS : Appeals Court Grants Stay of Permanent Injunction fo..
02/16 SANOFI : Researchers' Work from Sanofi Pasteur Focuses on Hepatitis (Immunogenic..
02/16 SANOFI : Researchers from Sanofi Report Recent Findings in Osteoarthritis (I kap..
02/16 SANOFI : brings Toujeo to local market
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/16 IPSEN : Acquires Five Sanofi Consumer Healthcare Products
02/15 SANOFI -FEBRUARY 4&15 : World Cancer Days
More news
Sector news : Pharmaceuticals - NEC
04:12pDJASTRAZENECA : Hyperkalaemia Drug Clears Scientific Hurdle for European Approval
02:02pDJASTRAZENECA : Gets Approval for Drug Treating Hyperkalaemia
12:59a Exclusive - Trump says Republican border tax could boost U.S. jobs
02/23DJPFIZER : Files 8K - Changes Executive Management
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
09:42a SYNERGY : 3 Scenarios, 1 Choice
02/22 Should Merck, BMS Fear Roche's Drug Becoming The I-O King?
02/21 PROTALIX BIOTHERAPEUTICS : New Institutional Ownership Swells Ahead Of Major Cat..
02/21 A Time To Buy Novo Nordisk
02/21 HEPATITIS B MARKET : Emerging Players Could Make The Difference
Advertisement
Financials (€)
Sales 2017 36 457 M
EBIT 2017 9 209 M
Net income 2017 5 873 M
Debt 2017 4 692 M
Yield 2017 3,81%
P/E ratio 2017 14,76
P/E ratio 2018 16,80
EV / Sales 2017 2,97x
EV / Sales 2018 2,84x
Capitalization 103 530 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 82,3 €
Spread / Average Target 2,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI4.38%109 628
JOHNSON & JOHNSON3.74%331 089
ROCHE HOLDING LTD.5.98%209 906
PFIZER INC.3.42%206 688
NOVARTIS AG3.51%201 806
MERCK & CO., INC.10.91%181 558
More Results